Financials data is unavailable for this security.
View more
Year on year Sino Medical Sciences Technology Inc grew revenues 77.99% from 192.85m to 343.26m while net income improved from a loss of 162.38m to a smaller loss of 39.63m.
| Gross margin | 60.22% |
|---|---|
| Net profit margin | -0.98% |
| Operating margin | -5.07% |
| Return on assets | -0.34% |
|---|---|
| Return on equity | -0.55% |
| Return on investment | -0.41% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Sino Medical Sciences Technology Inc fell by 14.78m. Cash Flow from Financing totalled 122.32m or 35.63% of revenues. In addition the company generated 56.84m in cash from operations while cash used for investing totalled 193.04m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 2.07 |
|---|---|
| Tangible book value per share | 0.539 |
More ▼
Balance sheet in CNYView more
| Current ratio | 2.38 |
|---|---|
| Quick ratio | 1.61 |
| Total debt/total equity | 0.1603 |
|---|---|
| Total debt/total capital | 0.1327 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items increased 75.59%.
| Div yield(5 year avg) | 0.18% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 95.17 |
More ▼
